Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Rheumatology and Immunology Research is Scopus-indexed (Q2, CiteScore 4), WoS ESCI. Published by Walter de Gruyter GmbH.
Checked against the index lists dated .
ISSN 2719-4523Verify ISSN ↗
Publisher: Walter de Gruyter GmbH
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 72 / 179 | 60th | Q2 |
| Rheumatology | 34 / 77 | 56th | Q2 |
| Immunology and Allergy | 141 / 234 | 39th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q2, CiteScore 4.
Rheumatology and Immunology Research is Q2 in Internal Medicine (rank 72 of 179), Q2 in Rheumatology (rank 34 of 77) and Q3 in Immunology and Allergy (rank 141 of 234), by CiteScore 2025.
Rheumatology and Immunology Research is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4, which places it in quartile Q2 at the 60th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.855, quartile Q2, with an H-index of 14.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Rheumatology and Immunology Research is published by Walter de Gruyter GmbH. Its ISSN is 2719-4523.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Rheumatology and Immunology Research has an h-index of 18 and a 2-year mean of 2.57 citations per paper (OpenAlex). Its Scopus CiteScore is 4, quartile Q2. On 2-year citations it ranks #51 of 172 Scopus journals in Internal Medicine.
Rheumatology and Immunology Research published 32 papers in 2025; its busiest recent year was 2022 with 37. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2023–2026), authors are most often from China (49.5%), Italy (8.5%) and United States (8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.